APOH and thrombophilia: Although poorly understood, multiple factors, including disseminated intravascular coagulation, hypercoagulability, thrombophilia with anticardiolipin or anti-β2GP1 antibodies, cardiac injury, and arrhythmia, have been proposed in the etiology of stroke in patients with COVID-19 (7–9).